| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,312 |
3,804 |
$186K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,385 |
5,524 |
$157K |
| 99490 |
Ccm add 20min |
1,570 |
1,496 |
$32K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,707 |
1,305 |
$5K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
18 |
18 |
$2K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
12 |
12 |
$1K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
13 |
13 |
$880.43 |
| 94060 |
|
95 |
92 |
$96.63 |
| 94667 |
|
202 |
189 |
$81.97 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
202 |
189 |
$56.08 |
| 93000 |
|
108 |
106 |
$43.96 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
838 |
708 |
$12.83 |
| 36415 |
Collection of venous blood by venipuncture |
14 |
14 |
$5.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,063 |
857 |
$3.64 |
| 4010F |
|
362 |
338 |
$0.02 |
| 1159F |
|
1,036 |
980 |
$0.01 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
46 |
38 |
$0.00 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
54 |
53 |
$0.00 |
| G8419 |
Bmi documented outside normal parameters, no follow-up plan documented, no reason given |
483 |
427 |
$0.00 |
| G9664 |
Patients who are currently statin therapy users or received an order (prescription) for statin therapy |
27 |
26 |
$0.00 |
| 3008F |
|
138 |
126 |
$0.00 |
| 3048F |
|
59 |
56 |
$0.00 |
| 1126F |
|
527 |
499 |
$0.00 |
| 3074F |
|
246 |
240 |
$0.00 |
| 1125F |
|
181 |
174 |
$0.00 |
| 1170F |
|
110 |
107 |
$0.00 |
| 3044F |
|
12 |
12 |
$0.00 |
| 3079F |
|
33 |
32 |
$0.00 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
12 |
12 |
$0.00 |
| 3049F |
|
15 |
15 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
14 |
13 |
$0.00 |
| 1111F |
|
12 |
12 |
$0.00 |
| 3078F |
|
210 |
210 |
$0.00 |
| 4013F |
|
293 |
277 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
975 |
895 |
$0.00 |
| 3288F |
|
92 |
88 |
$0.00 |
| 1158F |
|
88 |
85 |
$0.00 |
| 1160F |
|
776 |
733 |
$0.00 |
| 3725F |
|
77 |
75 |
$0.00 |
| 3077F |
|
17 |
17 |
$0.00 |